Elbasvir/Grazoprevir
성인

성인

1 tab = Elbasvir 50 mg/Grazoprevir 100 mg

Genotype 1

국내허가사항

Genotype 1a, treatment-naïve or Peg IFN/RBV-experienced 1 tab PO once daily x12w

Genotype 1a, with or without baseline NS5A polymorphism, treatment-naïve or treatment failure with Peginterferon alfa and Ribavirin

1 tab PO once daily x12w

Genotype 1a, with baseline NS5A polymorphism, treatment-naïve or treatment failure with Peginterferon alfa and Ribavirin
  • BW <66 kg: 1 tab PO once daily x16w + Ribavirin 800 mg/d
  • BW 66-80 kg: 1 tab PO once daily x16w + Ribavirin 1,000 mg/d
  • BW 81-105 kg: 1 tab PO once daily x16w + Ribavirin 1,200 mg/d
  • BW >105 kg: 1 tab PO once daily x16w + Ribavirin 1,400 mg/d
Genotype 1b, treatment-naïve or treatment failure Peginterferon alfa and Ribavirin

1 tab PO once daily x12w

Genotype 1a/1b, treatment failure with Peginterferon alfa, Ribavirin, and HCV NS3/4A protease inhibitor
  • BW <66 kg: 1 tab PO once daily x12w + Ribavirin 800 mg/d
  • BW 66-80 kg: 1 tab PO once daily x12w + Ribavirin 1,000 mg/d
  • BW 81-105 kg: 1 tab PO once daily x12w + Ribavirin 1,200 mg/d
  • BW >105 kg: 1 tab PO once daily x12w + Ribavirin 1,400 mg/d

Genotype 4

Treatment-naïve

1 tab PO once daily x12w

Treatment failure with Peginterferon alfa and Ribavirin
  • BW <66 kg: 1 tab PO once daily x16w + Ribavirin 800 mg/d
  • BW 66-80 kg: 1 tab PO once daily x16w + Ribavirin 1,000 mg/d
  • BW 81-105 kg: 1 tab PO once daily x16w + Ribavirin 1,200 mg/d
  • BW >105 kg: 1 tab PO once daily x16w + Ribavirin 1,400 mg/d

No renal dose adjustment